Related references
Note: Only part of the references are listed.Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables
Nicole A. Doria-Rose et al.
JOURNAL OF VIROLOGY (2010)
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals
Davide Corti et al.
PLOS ONE (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
Bruno E. Correia et al.
STRUCTURE (2010)
Epitope specificities of broadly neutralizing plasmas from HIV-1 infected subjects
D. Noah Sather et al.
VACCINE (2010)
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals
Laura M. Walker et al.
PLOS PATHOGENS (2010)
Selective Expansion of HIV-1 Envelope Glycoprotein-Specific B Cell Subsets Recognizing Distinct Structural Elements Following Immunization
Pia Dosenovic et al.
JOURNAL OF IMMUNOLOGY (2009)
Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma
Katie L. Davis et al.
JOURNAL OF VIROLOGY (2009)
Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals
Yuxing Li et al.
JOURNAL OF VIROLOGY (2009)
Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope
Gail Ferstandig Arnold et al.
JOURNAL OF VIROLOGY (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination
Katie L. Davis et al.
VIROLOGY (2009)
Structure-Based Stabilization of HIV-1 gp120 Enhances Humoral Immune Responses to the Induced Co-Receptor Binding Site
Barna Dey et al.
PLOS PATHOGENS (2009)
Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site
Jean-Philippe Julien et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies
Gary Frey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models
Bruce K. Brown et al.
VIROLOGY (2008)
Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies
Cecilia Rademeyer et al.
VIROLOGY (2007)
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
Yuxing Li et al.
NATURE MEDICINE (2007)
Dissecting the neutralizing antibody-specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors
Amandeep K. Dhillon et al.
JOURNAL OF VIROLOGY (2007)
Immunogenicity of a chimeric hepatitis A virus (HAV) carrying the HIV gp41 epitope 2F5
Yuri Y. Kusov et al.
ANTIVIRAL RESEARCH (2007)
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in southern Africa
Ming Li et al.
JOURNAL OF VIROLOGY (2006)
Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity
Martine Braibant et al.
AIDS (2006)
Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment
M Luo et al.
VACCINE (2006)
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies
BF Haynes et al.
SCIENCE (2005)
Conformational constraints imposed on a pan-neutralizing HIV-1 antibody epitope result in increased antigenicity but not neutralizing response
J Ho et al.
VACCINE (2005)
Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine papillomavirus-HIV-1 gp41 chimeric virus-like particles
HT Zhang et al.
JOURNAL OF VIROLOGY (2004)
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know
G Pantaleo et al.
NATURE MEDICINE (2004)
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope
G Ofek et al.
JOURNAL OF VIROLOGY (2004)
Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion
G Barbato et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions
JM Binley et al.
JOURNAL OF VIROLOGY (2003)
A monomeric 310-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41
Z Biron et al.
BIOCHEMISTRY (2002)
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1
G Stiegler et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles
DJ Schibli et al.
BIOCHEMISTRY (2001)
Immunologic correlates of protection induced by vaccination
SA Plotkin
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein
E Coëffier et al.
VACCINE (2000)
Share Paper
